Publications Library

Explore Sarepta’s library to find peer-reviewed publications by therapeutic area or program from 2018 onward.
The publications below are provided to support scientific exchange.
Publications may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Sarepta does not recommend or suggest the use of any of its products beyond the approved Prescribing Information.

Questions?

Connect with one of our Medical Science Liaisons or submit a Medical Information Request
Search Sarepta’s Publications Library
Reset
Therapeutic Area
Study Type
Product/Program
Interested in Sarepta's Congress Presentations?
Access the Sarepta Congress Hub
Characterizing the Quality-of-Life Impact of Duchenne Muscular Dystrophy on Caregivers: a Case-Control Investigation
Authors: Schwartz CE, Stark RB, Audhya IF, Gooch KL
Journal: Journal of Patient-Reported Outcomes
Published: 20 November 2021
Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: a First-In-Human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial
Authors: Servais L, Mercuri E, Straub V, Guglieri M, Seferian AM, Scoto M, Leone D, Koenig E, Khan N, Dugar A, Wang X, Han B, Wang D, Muntoni F, SKIP-NMD Study Group
Journal: Nucleic Acid Therapeutics
Published: 17 November 2021
Antisense Oligonucleotides: Absorption, Distribution, Metabolism, and Excretion
Authors: Shadid M, Badawi M, Abulrob A
Journal: Expert Opinion on Drug Metabolism & Toxicology
Published: 22 October 2021
Pharmacokinetic/Pharmacodynamic Modeling of a Cell-Penetrating Peptide Phosphorodiamidate Morpholino Oligomer in Mdx Mice
Authors: Mukashyaka MC, Wu CL, Ha K, Zhang J, Wood J, Foley S, Mastis B, Jungels N, Sun H, Shadid M, Harriman S, Hadcock JR
Journal: Pharmaceutical Research
Published: 20 October 2021
Characterizing Demographics, Comorbidities and Costs of Care Among Populations With Duchenne Muscular Dystrophy With Medicaid and Commercial Coverage
Authors: Klimchak AC, Szabo SM, Qian C, Popoff E, Iannaccone S, Gooch KL
Journal: Journal of Managed Care & Specialty Pharmacy
Published: 01 October 2021
Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy
Authors: Landfeldt E, Iff J, Henricson EK
Journal: Value in Health
Published: 09 September 2021

Welcome to
Sarepta Medical

The resources contained within this website may include educational resources and information relating to medicines and therapeutic areas of interest, congress materials and publications.

This website is intended for U.S. healthcare professionals only. The content on the website is for personal, educational use only. No further reproduction or distribution is permitted without permission from copyright owner(s)

Please confirm below to continue:

I am NOT a US healthcare professional
Continue to
External URL